DXL Board Unanimously Rejects Zodiac's Revised $0.84/Share Tender Offer
DXLG sits 47% above its 52-week low of $0.435.
Summary
Destination XL Group's Board has unanimously rejected Zodiac Partners II's revised $0.84 per share tender offer, asserting the bid undervalues the company despite being a premium to the current stock price.
Key Events · M&A and Partnerships · DXLG
-
Board Rejects Revised Tender Offer
The Board of Directors unanimously recommended stockholders reject Zodiac Partners II's revised $0.84 per share all-cash tender offer.
-
Undervaluation Claim
The Board stated the revised offer still 'undervalues DXL' and is not in the best interests of stockholders, despite being a premium to the current market price.
-
Share Withdrawal Option
Stockholders who have already tendered their shares may withdraw them at any point prior to the offer's expiration on July 24, 2026.
-
Ongoing M&A Battle
This marks another rejection in the ongoing unsolicited takeover attempt by Zodiac Partners II, following a previous rejection of a $0.82 per share offer.
Analysis · DXLG · Trade & Services
The Board of Directors of Destination XL Group has unanimously recommended shareholders reject Zodiac Partners II's increased tender offer of $0.84 per share, stating it still undervalues the company. This decision prolongs the uncertainty surrounding the company's future ownership and strategy, especially given its recent financial struggles and the premium offered by Zodiac compared to the current stock price.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 41.2% of the 374 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DXLG was trading at $0.64 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $34.7M. The 52-week trading range was $0.44 to $1.69. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.